Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof

US10583161B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10583161-B2
Application numberUS-201715808580-A
CountryUS
Kind codeB2
Filing dateNov 9, 2017
Priority dateJun 16, 2014
Publication dateMar 10, 2020
Grant dateMar 10, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions and methods for bone health, cartilage health or both, are disclosed that include preparing and utilizing a mixture of at least one Morus extract enriched for one or more prenylated flavonoids, at least one Scutellaria extract enriched for one or more free-B-ring flavonoids, and at least one Acacia extract enriched for one or more flavans.

First claim

Opening claim text (preview).

We claim: 1. A composition for bone health, cartilage health or both, comprising a mixture of at least one Morus extract enriched for one or more prenylated flavonoids, at least one Scutellaria extract enriched for one or more free-B-ring flavonoids, and at least one Acacia extract enriched for one or more flavans, wherein the Morus extract, the Scutellaria extract, and the Acacia extract are blended in a 1.3:1:1 weight ratio. 2. The composition according to claim 1 , wherein the Morus extract is from Morus alba , the Scutellaria extract is from Scutellaria baicalensis , and the Acacia extract is from Acacia catechu. 3. The composition according to claim 1 , wherein the Acacia extract comprises 0.01% to 99.9% flavans. 4. The composition according to claim 1 , wherein the Morus extract comprises 0.1% to 49.9% prenylated flavonoids. 5. The composition according to claim 1 , wherein the Scutellaria extract comprises 0.01% to 99.9% free-B-ring flavonoids. 6. The composition according to claim 1 , wherein the one or more prenylated flavonoids comprises Kuwanon G. 7. The composition according to claim 1 , wherein the one or more flavans comprises catechin. 8. The composition according to claim 1 , wherein the composition additionally comprises a glucosamine-type compound. 9. The composition according to claim 8 , wherein the glucosamine-type compound comprises glucosamine sulfate. 10. The composition according to claim 1 , wherein the composition further comprises a pharmaceutically or nutraceutically acceptable carrier, diluent, or excipient, wherein the pharmaceutical or nutraceutical formulation comprises from about 0.5 weight percent (wt %) to about 90 wt % of active ingredients of the extract mixture. 11. The composition according to claim 10 , wherein the composition is formulated as a tablet. 12. A composition for bone health, cartilage health or both, comprising a mixture of at least one Moms extract enriched for one or more prenylated flavonoids, at least one Scutellaria extract enriched for one or more free-B-ring flavonoids, and at least one Acacia extract enriched for one or more flavans, wherein the Morus extract, the Scutellaria extract, and the Acacia extract are blended in a 0.410:0.308:0.282 weight ratio.

Assignees

Inventors

Classifications

  • Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae · CPC title

  • Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00 · CPC title

  • 3,4-Dihydrobenzopyrans, e.g. chroman, catechin · CPC title

  • A61K36/605Primary

    Morus (mulberry) · CPC title

  • Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate (A61K31/727 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10583161B2 cover?
Compositions and methods for bone health, cartilage health or both, are disclosed that include preparing and utilizing a mixture of at least one Morus extract enriched for one or more prenylated flavonoids, at least one Scutellaria extract enriched for one or more free-B-ring flavonoids, and at least one Acacia extract enriched for one or more flavans.
Who is the assignee on this patent?
Unigen Inc
What technology area does this patent fall under?
Primary CPC classification A61K36/605. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).